Global Biomarkers Market Will Reach USD 108.4 Billion By 2025: Zion Market Research

According to the report, the global biomarkers market was USD 41.2 billion in 2018 and is expected to generate around USD 108.4 billion by 2025, at a CAGR of around 14.8% between 2019 and 2025.

Sarasota, Florida, UNITED STATES


New York, NY, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global biomarkers market was USD 41.2 billion in 2018 and is expected to generate around USD 108.4 billion by 2025, at a CAGR of around 14.8% between 2019 and 2025.

A biomarker is a substance that can be introduced among organisms to inspect organ functions or other aspects of their health. A biomarker is objectively evaluated and measured as an indication of typical pathogenic processes, biological processes, or pharmacologic responses to therapeutic interventions. Biomarkers indicate a wide range of diseases or health characteristics along with the type or level of exposure to an environmental factor, genetic responses, genetic susceptibility to environmental exposure, markers of clinical or subclinical diseases, and indicators of response to therapy.

Browse through 54 Tables & 30 Figures spread over 110 Pages and in-depth TOC on “Global Biomarkers Market Size Share 2018 Report: Industry Type, Applications, Growth, Analysis, and Forecast till 2025”.

Request Free Sample Report of Global Biomarkers Market @ https://www.zionmarketresearch.com/sample/biomarkers-market

The global cancer biomarkers market is fragmented based on biomarker type, application, and disease. Based on biomarker type, the biomarkers market is categorized into safety, validation, and efficacy biomarkers. Safety biomarkers accounted for the highest market share in 2018, due to the increasing product adoption in drug discovery and development. Moreover, they are used in trials for preclinical studies to select drug candidates probable to be well-tolerated by individuals, which helps in decreasing cost and time for evaluation of drug development and preclinical safety.

Based on application, the biomarkers market includes personalized medicine, diagnostic, drug discovery and development, and others. Drug discovery and development accounted for a major market share in 2018. Biomarkers affect the major market players’ decision regarding whether to continue with the later phases of clinical developments. Additionally, pharmaceutical giants are undertaking an increasing number of R&D initiatives to develop targeted therapeutics.

Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/biomarkers-market
 
By disease, the biomarkers market comprises immunological diseases, cancer, neurological diseases, cardiovascular diseases, and others. The cancer segment dominates the global biomarkers market, due to the growing demand for accurate and rapid diagnostic tools and rising cancer incidences globally. According to the National Cancer Institute, about 268,670 new cases of breast cancer were recorded in 2018 in the U.S.

North America dominated the biomarkers market globally in 2018 and is likely to remain dominant over the forecast time period as well. This regional dominance can be attributed to the regional presence of major pharmaceutical and biotechnology companies, increasing adoption of the latest technologies, and established healthcare infrastructure. The U.S. is the leading biomarkers market in North America, which is expected to register the highest CAGR in the years ahead. Moreover, government funding for research activities will also boost this regional market. According to the National Cancer Institute, in the U.S., in 2016, around 16.8 million new cancer cases were detected in the country and 5,95,690 deaths were caused by cancer. Furthermore, the collaboration of government with several research institutes to improve the research on cancer and other chronic diseases for diagnostics and treatment purpose will further fuel this market.

Browse the full “Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/biomarkers-market

The Asia Pacific region is expected to record high growth in the biomarkers market globally in the years ahead. The rising incidences of chronic diseases like neurological disorders, cancer, and cardiovascular diseases, growing support of the regional governments for drug discovery and development programs, accelerating biomarkers awareness for diseases diagnosis, and large patient pool are the major factors boosting the biomarkers market development in the Asia Pacific. China, Japan, and India are predicted to be major contributors to the Asia Pacific biomarkers market in the future. The favorable environment for clinical trials in the Asia Pacific is likely to fuel the biomarkers market over the forecast period.

The Middle East and Africa and Latin America hold the least shares in the global biomarkers market, due to the lack of awareness about advanced diagnostic techniques and high cost of diagnosis and treatment.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biomarkers-market

Some key players in the global biomarkers market are Agilent Technologies, F. Hoffmann-La Roche, Epigenomics, Abbott, Thermo Fisher Scientific, Johnson & Johnson, Siemens Healthcare, Bio-Rad Laboratories, and Qiagen.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/4750

This report segments the global biomarkers market into:

Global Biomarkers Market: Biomarker Type Analysis

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

Global Biomarkers Market: Application Analysis

  • Diagnostic
  • Drug Discovery and Development
  • Personalized Medicine
  • Others

Global Biomarkers Market: Technology Analysis

  • Cancer
  • Cardiovascular Diseases
  • Neurological Diseases
  • Immunological Diseases
  • Others

Global Biomarkers Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://newszmr.com